

Toutes les ressources et actualités à portée de main
Le processus de découverte et de développement d’une molécule est complexe, long et couteux. Avant de prendre une décision sur l’offre qui répond au mieux à votre besoin, nous vous proposons des ressources scientifiques (posters, publications, webinaires) en ligne, nos dernières actualités (congrès, communiqués de presse) pour mieux nous connaitre et nous rencontrer. Nos experts sont également à votre disposition pour vous aider et vous accompagner dans votre programme de recherche et développement.
- Tous
- Congress
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités

Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology
AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!

PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!

Radioligand Binding Assays: A Lost Art in Drug Discovery?
Old-school or still essential? Explore the overlooked power of radioligand binding assays in today's research environment.

Webinar – Hidden Potential: Using Fragments to Uncover New Ligandable Sites on Popular Targets
Learn how fragments reveal novel opportunities in well-known drug targets. Watch the webinar to explore strategies, case studies, and actionable insights.

White Paper: Discovering & Advancing Molecular Glues Using a Cooperativity-Based Approach
Discover how a cooperativity-driven approach accelerates molecular glue discovery. Download the white paper to learn more about the science and strategy.

PDX Research Model Guide
Explore 200+ PDX models across 14 indications. Better predict clinical response with fully characterized, customizable models. Download now.

Oncodesign Services appoints Aidan Synnott as CEO to enhance strategic drug discovery partnerships
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery.

Publication: The Nature of Nanodisc Lipids Influences Fragment-Based Drug Discovery Results
Discover how nanodisc lipids impact fragment-based drug discovery, enhancing membrane protein screening and enabling new therapeutic possibilities.

Cooperativity: The Missing Link in Molecular Glue Discovery
In this Q&A, discover how cooperativity is unlocking new potential in molecular glues and enabling the targeting of previously “undruggable” proteins.

Case study: Capturing out-of-range target engagement kinetics for an advanceable clinical candidate
Characterizing the inhibition of PRMT5:MTA by MRTX1719, a clinical stage MTAP-deleted cancer therapeutic.